Apply for Funding

CPRIT offers several funding opportunities for promising cancer research, product development, and prevention programs. All funding opportunities are announced through formal Requests for Applications (RFAs) and applications must be submitted through the online application receipt system.

Learn more about the grants process.

Evidence-Based Cancer Prevention Services

Program Prevention
RFA Status Open
Description

This award mechanism seeks to fund projects that will deliver evidence-based cancer prevention and control clinical services. Priority will be given to projects that propose to address CPRIT areas of emphasis and serve areas of the state not well addressed by current CPRIT funded projects. Only proposals for new projects are eligible under this mechanism. Eligible applications must include the delivery of services to nonmetropolitan (rural) and medically underserved counties in the state.

Award: Maximum of $1M; Maximum duration of 36 months.

Review Cycle Fiscal Year 2022 - Cycle 2
RFA Release October 19, 2021
Application Receipt November 15, 2021 - February 09, 2022
Application Review March 2022 - July 2022
Award Notification August 2022

Expansion of Cancer Prevention Services to Rural and Medically Underserved Populations

Program Prevention
RFA Status Open
Description

This award mechanism seeks to support the coordination and expansion of evidence based services to prevent cancer in underserved populations who do not have adequate access to cancer prevention interventions and health care, bringing together networks of public health and community partners to carry out programs tailored for their communities. Projects should identify cancers that cause the most burden in the community and use evidence-based models shown to work in similar communities to prevent and control these cancers. For the first expansion application, eligible applicants should propose to expand their programs to include additional types of prevention clinical services and/or an expansion of current clinical services into additional counties. For a subsequent expansion, additional clinical services and/or expansion to additional counties is optional; the number of clinical services delivered must be increased substantially if no further geographic or clinical service expansion is proposed.

Initial Expansion: up to $2M over 36 months

Maintenance Expansion: up to $2.5M over 60 months

Review Cycle Fiscal Year 2022 - Cycle 2
RFA Release October 19, 2021
Application Receipt November 15, 2021 - February 09, 2022
Application Review March 2022 - July 2022
Award Notification August 2022

Tobacco Control and Lung Cancer Screening

Program Prevention
RFA Status Open
Description

This award mechanism seeks to fund programs on tobacco prevention and cessation, as well as screening for early detection of lung cancer. Through release of this RFA, CPRIT’s goal is to stimulate more programs across the state, thereby providing greater access for underserved populations and reducing the incidence and mortality rates of tobacco-related cancers. This RFA seeks to promote and deliver evidence-based programming designed to significantly increase tobacco cessation among adults and/or prevent tobacco use by youth.

Award: Maximum of $1 M; Maximum duration of 36 months

Review Cycle Fiscal Year 2022 - Cycle 2
RFA Release October 19, 2021
Application Receipt November 15, 2021 - February 09, 2022
Application Review March 2022 - July 2022
Award Notification August 2022

Texas Regional Excellence in Cancer Award (TREC)

Program Academic Research
RFA Status Open
Description

Solicits applications to strengthen cancer research at institutions located in regions of Texas that have historically received low levels of peer reviewed cancer research funding.

Award: Up to $6,000,000 (total costs); Maximum duration: 5 years.

Review Cycle Fiscal Year 2023 - Cycle 1
RFA Release September 27, 2021
Application Receipt May 16, 2022 - September 08, 2022
Application Review September 2022 - November 2022
Award Notification January 2023

Clinical Trials Network Award (CTNA)

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

The Clinical Trials Network Award (CTNA) will be made to Lead Institutions (LI) to develop and oversee a network of two cancer care facilities (Network Affiliates) (Stage 1) to extend access to a select group of LI cancer clinical trials. Once an initial network is satisfactorily demonstrated, the LI will be eligible to receive additional CPRIT funding to expand its network to two additional facilities that must be located outside the LI current catchment area (Stage 2).

Award: Up to $600,000 annually for stage 1 and up to $900,000, annually for stage 2. Maximum duration: 4 years

Review Cycle Fiscal Year 2022 - Cycle 2
RFA Release August 30, 2021
Application Receipt October 13, 2021 - January 12, 2022
Application Review January 2022 - August 2022
Award Notification August 2022

Core Facility Support Awards (CFSA)

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Solicits applications from institutions to establish or enhance core facilities (laboratory, clinical, population-based, or computer-based) that will directly support cancer research programs to advance knowledge of the causes, prevention, and/or treatment of cancer or improve quality of life for cancer patients during or after treatment.

Award: Up to $4,000,000 (total costs); Maximum duration: 5 years.

Review Cycle Fiscal Year 2022 - Cycle 2
RFA Release August 30, 2021
Application Receipt October 13, 2021 - January 12, 2022
Application Review January 2022 - August 2022
Award Notification August 2022

Early Clinical Investigator Award (ECI)

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Solicits applications from institutions to provide cancer physicians early in their academic career the opportunity to develop clinical research skills and to gain experience in advanced methods and experimental approaches needed to become clinical investigators; to provide an opportunity to establish a partnership with a laboratory-based collaborator in order to design and conduct correlative studies needed to interpret the outcome of an interventional trial; to provide the protected time from clinical responsibilities required to develop and conduct investigator initiated clinical trials; and to increase the pool of clinical investigators at Texas academic institutions who are conducting patient-oriented studies, capitalizing on basic discoveries and translating them through conduct of innovative clinical trials involving cancer patients or individuals at risk for cancer.

Award: Up to $1,5000,000 (total costs) Maximum duration: 5 years

Review Cycle Fiscal Year 2022 - Cycle 2
RFA Release August 30, 2021
Application Receipt October 13, 2021 - January 12, 2022
Application Review January 2022 - August 2022
Award Notification August 2022

High-Impact/High-Risk Research Awards (HIHR)

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Provides short-term funding to explore the feasibility of high-risk projects that, if successful, would contribute major new insights into the etiology, diagnosis, treatment, or prevention of cancers.

Award: Up to $250,000 (total costs); Maximum duration: 2 years.

Review Cycle Fiscal Year 2022 - Cycle 2
RFA Release August 30, 2021
Application Receipt October 13, 2021 - January 12, 2022
Application Review January 2022 - August 2022
Award Notification August 2022

Recruitment of Established Investigators

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Recruits outstanding senior research faculty with distinguished professional careers and established cancer research programs to academic institutions in Texas.

Award: Up to $6 million over a period of five years.

Review Cycle Fiscal Year 2022 - Cycle 1
RFA Release June 22, 2021
Application Receipt June 22, 2021 - June 20, 2022
Application Review Continuous
Award Notification Continuous

Recruitment of First-Time, Tenure-Track Faculty Members

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Supports very promising emerging investigators, pursuing their first faculty appointment in Texas, who have the ability to make outstanding contributions to the field of cancer research.

Award: Up to $2 million up to a period of five years.

Review Cycle Fiscal Year 2022 - Cycle 1
RFA Release June 22, 2021
Application Receipt June 22, 2021 - June 20, 2022
Application Review Continuous
Award Notification Continuous

Recruitment of Rising Stars

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Recruits outstanding early-stage investigators to Texas, who have demonstrated the promise for continued and enhanced contributions to the field of cancer research.

Award: Up to $4 million over a period of five years.

Review Cycle Fiscal Year 2022 - Cycle 1
RFA Release June 22, 2021
Application Receipt June 22, 2021 - June 20, 2022
Application Review Continuous
Award Notification Continuous